Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 6569539Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Internal Medicine
NIH Funding · FY2024
Linked Award Amount
$4.7M
Full award amounts, FY2024
Award Records
4
Records listing this PI
Award-Linked Rank
#1,228
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2024 award records by amount
NIH award records listing Mark T Gladwin as a PI. Multi-PI records show the full award amount for context.
- 5UH3HL143192-07UH3Sickle Cell Disease and Cardiovascular Risk- Red Cell Exchange SCD-CARRE$2.6Maward amount
- 5R01HL098032-15R01Omics, mice and men: Development of precision transfusion medicine$750.6Kaward amount
- 1R01HL168775-01A1R01Airway epithelial cytoglobin regulates nitric oxide synthase and development of primary ciliary dyskinesia and situs inversus$724.9Kaward amount
- 5R01HL125886-10R01Antidote for inhaled CO poisoning based on mutationally engineered neuroglobin$660.8Kaward amount
Award organization
Organizations that administered FY2024 awards listing Mark T Gladwin as a PI.
FY2024 award administered by University of Maryland Baltimore (MD).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardUniversity of Maryland Baltimore
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #1228
- 2024Entered Top 25% NationallyRanked #1228
- 2024Entered Top 10% NationallyRanked #1228
- 2025$5M Cumulative Funding
- 2025R01 Grant Holder
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Mark T Gladwin.